Alan Kluger

Affiliations: 
Psychology City University of New York, New York, NY, United States 
Area:
Cognitive Psychology
Google:
"Alan Kluger"
Mean distance: 35622
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Guerrero-Berroa E, Kluger A, Schmeidler J, et al. (2014) Neuropsychological and neuropsychiatric prediction of global cognitive status among older Spanish-speaking Hispanics and English-speaking whites. Journal of Geriatric Psychiatry and Neurology. 27: 266-75
Yau PL, Kluger A, Borod JC, et al. (2014) Neural substrates of verbal memory impairments in adults with type 2 diabetes mellitus. Journal of Clinical and Experimental Neuropsychology. 36: 74-87
Reisberg B, Jamil IA, Khan S, et al. (2010) Staging Dementia Principles and Practice of Geriatric Psychiatry: Third Edition. 162-169
Myers CE, Kluger A, Golomb J, et al. (2008) Learning and generalization tasks predict short-term cognitive outcome in nondemented elderly. Journal of Geriatric Psychiatry and Neurology. 21: 93-103
Reisberg B, Ferris SH, Kluger A, et al. (2008) Mild cognitive impairment (MCI): a historical perspective. International Psychogeriatrics / Ipa. 20: 18-31
Sailor K, Antoine M, Diaz M, et al. (2004) The Effects of Alzheimer's Disease on Item Output in Verbal Fluency Tasks Neuropsychology. 18: 306-314
Myers CE, Shohamy D, Gluck MA, et al. (2003) Dissociating hippocampal versus basal ganglia contributions to learning and transfer. Journal of Cognitive Neuroscience. 15: 185-93
Myers CE, Kluger A, Golomb J, et al. (2002) Hippocampal atrophy disrupts transfer generalization in nondemented elderly. Journal of Geriatric Psychiatry and Neurology. 15: 82-90
Reisberg B, Ferris SH, Franssen EH, et al. (1996) Mortality and temporal course of probable Alzheimer's disease: a 5-year prospective study. International Psychogeriatrics / Ipa. 8: 291-311
Reisberg B, Franssen EH, Bobinski M, et al. (1996) Overview of methodologic issues for pharmacologic trials in mild, moderate, and severe Alzheimer's disease. International Psychogeriatrics / Ipa. 8: 159-93
See more...